Clinical Trial Update: Weight-based Dosing for Dense Weekly Paclitaxel and Carboplatin in Overweight Patients w/ Body Surface Area (BSA) > 2.0 [Phase 2]

View source ↗

Summary

Phase 2 trial update on weight-based dosing for dense weekly paclitaxel and carboplatin in overweight patients (BSA > 2.0) with gynecologic malignancies; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gynecologic Malignancies

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Gynecologic Malignancies | Phase 2 | Status: TERMINATED | Results posted: 2020-08-06